Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Helen Mejia Santana"'
Autor:
Yaqian Xu, Anat Mirelman, Rachel Saunders-Pullman, Helen Mejia-Santana, Elise Caccappolo, Deborah Raymond, Nir Giladi, Susan Bressman, Karen Marder, Roy N. Alcalay
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 3, Iss , Pp 100042- (2020)
Introduction: The Montreal Cognitive Assessment (MoCA), an instrument widely used for cognitive screening in Parkinson's disease (PD), is validated in Hebrew and English. However, it remains unknown whether the scores are comparable. Methods: The MoC
Externí odkaz:
https://doaj.org/article/b1c901a8efd34bf1b1cc0a1c6e220951
Autor:
Rachel Saunders-Pullman, Roberto Angel Ortega, Cuiling Wang, Deborah Raymond, Sonya Elango, Katherine Leaver, Nikita Urval, Viktoriya Katsnelson, Rachel Gerber, Matthew Swan, Vicki Shanker, Roy N. Alcalay, Anat Mirelman, Michael C. Brumm, Helen Mejia-Santana, Christopher S. Coffey, Kenneth Marek, Laurie J. Ozelius, Nir Giladi, Karen S. Marder, Susan B. Bressman
Publikováno v:
Neurology. 99:e814-e823
Background and ObjectivesThere is clinical and phenotypic heterogeneity in LRRK2 G2019S Parkinson disease (PD), including loss of smell. Olfactory scores have defined subgroups of LRRK2 PD at baseline. We now extend this work longitudinally to better
Autor:
Rachel, Saunders-Pullman, Roberto Angel, Ortega, Cuiling, Wang, Deborah, Raymond, Sonya, Elango, Katherine, Leaver, Nikita, Urval, Viktoriya, Katsnelson, Rachel, Gerber, Matthew, Swan, Vicki, Shanker, Roy N, Alcalay, Anat, Mirelman, Michael C, Brumm, Helen, Mejia-Santana, Christopher S, Coffey, Kenneth, Marek, Laurie J, Ozelius, Nir, Giladi, Karen S, Marder, Susan B, Bressman
Publikováno v:
Neurology
BACKGROUND AND OBJECTIVES: There is clinical and phenotypic heterogeneity in LRRK2 G2019S Parkinson disease (PD), including loss of smell. Olfactory scores have defined subgroups of LRRK2 PD at baseline. We now extend this work longitudinally to bett
Autor:
Paul Cannon, Laurie J. Ozelius, James E. Tomkins, Nir Giladi, Owen A. Ross, Emil K. Gustavsson, Avi Orr Urtreger, Ali Samii, Tae-Hwi Schwantes-An, Sayantan Das, Haydeh Payami, Claudia Schulte, Eduardo Tolosa, Timothy Lynch, Eden R. Martin, Matthew J. Farrer, Brian K. Fiske, Pierre Fontanillas, Eric Molho, Ryan J. Uitti, Babak Alipanahi, Dolores Vilas, Jan O. Aasly, Dongbing Lai, Richard H. Myers, William K. Scott, Gary W. Beecham, Jordan Follett, Thomas Gasser, John Q. Trojanowski, Zbigniew K. Wszolek, Jeanne C. Latourelle, Caroline M. Tanner, Joanne Trinh, Alexis Brice, Lorraine N. Clark, Roy N. Alcalay, Karen Marder, Susan Bressman, Deborah Raymond, Tatiana Foroud, Connie Marras, Kathrin Brockman, Birgitt Schüle, Cory Y. McLean, Rachel Saunders-Pullman, Ekaterina Rogaeva, Daniela Berg, Cyrus P. Zabetian, Stefano Goldwurm, Karen Nuytemans, Mark R. Cookson, Helen Mejia-Santana, Jeffery M. Vance, Christine Klein, Naomi P. Visanji, J. William Langston, Michael P. Rogers, Anthony E. Lang, Anat Mirelman, Vivianna M. Van Deerlin
Publikováno v:
Annals of neurology, vol 90, iss 1
Annals of neurology 90(1), 76-88 (2021). doi:10.1002/ana.26094
Annals of Neurology
Annals of neurology 90(1), 76-88 (2021). doi:10.1002/ana.26094
Annals of Neurology
Objective The aim of this study was to search for genes/variants that modify the effect of LRRK2 mutations in terms of penetrance and age-at-onset of Parkinson's disease. Methods We performed the first genome-wide association study of penetrance and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d85f9b8fa247e3ffc59892687c3c71a
https://escholarship.org/uc/item/09b4c8xm
https://escholarship.org/uc/item/09b4c8xm
Autor:
Ilir Agalliu, Sharon Hassin-Baer, Deborah Raymond, Daniela Berg, Javier Ruiz-Martínez, Marta San Luciano, Elisabet Mondragon, Bjorg Waro, Eduardo Tolosa, Kathrin Brockmann, Anat Mirelman, Nir Giladi, Rachel Saunders-Pullman, Roberto A. Ortega, Helen Mejia-Santana, Karen Marder, Jan O. Aasly, Dolores Vilas, Rivka Inzelberg, Amanda Glickman, Eitan Friedman, Susan Bressman, Roy N. Alcalay, Tatiana Foroud, Claustre Pont-Sunyer
Publikováno v:
Movement Disorders
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Movement disorders : official journal of the Movement Disorder Society, vol 34, iss 9
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Movement disorders : official journal of the Movement Disorder Society, vol 34, iss 9
Background Increased cancer risk has been reported in Parkinson's disease (PD) patients carrying the leucine rich repeat kinase 2 (LRRK2) G2019S mutation (LRRK2-PD) in comparison with idiopathic PD (IPD). It is unclear whether the elevated risk would
Autor:
Nir Giladi, Helen Mejia-Santana, Ekaterina Rogaeva, Connie Marras, Anthony E. Lang, Cyrus P. Zabetian, Stefano Goldwurm, Jeffery M. Vance, Birgitt Schüle, Cory Y. McLean, William K. Scott, Caroline M. Tanner, Karen Nuytemans, Ali Samii, Claudia Schulte, Emil K. Gustavsson, Eden R. Martin, Vivianna M. Van Deerlin, Dolores Vilas, Jan O. Aasly, Brian K. Fiske, Naomi P. Visanji, Pierre Fontanillas, Deborah Raymond, Alexis Brice, Dongbing Lai, John Q. Trojanowski, Zbigniew K. Wszolek, Thomas Gasser, Jeanne C. Latourelle, Joanne Trinh, Rachel Saunders-Pullman, Anat Mirelman, Christine Klein, Karen Marder, Mark R. Cookson, Roy N. Alcalay, Susan Bressman, Haydeh Payami, Tae-Hwi Schwantes-An, James E. Tomkins, Avi Orr Urtreger, Matthew J. Farrer, Tatiana Foroud, Daniela Berg, Eduardo Tolosa, Ryan J. Uitti, Babak Alipanahi, Timothy Lynch, Kathrin Brockman, Gary W. Beecham, Paul Cannon, Laurie J. Ozelius, Richard H. Myers, Lorraine N. Clark, Sayantan Das, Eric Molho, J. William Langston, Owen A. Ross, Michael P. Rogers
Objective: The aim of this study was to search for genes/variants that modify the effect of LRRK2 mutations in terms of penetrance and age-at-onset of Parkinson's disease. Methods: We performed the first genome-wide association study of penetrance an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e74537c5ca6b94faf72799c40152b956
https://doi.org/10.1101/2020.12.14.20224378
https://doi.org/10.1101/2020.12.14.20224378
Autor:
Elise Caccappolo, Nir Giladi, Helen Mejia-Santana, Karen Marder, Rachel Saunders-Pullman, Yaqian Xu, Roy N. Alcalay, Deborah Raymond, Susan B. Bressman, Anat Mirelman
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 3, Iss, Pp 100042-(2020)
Clinical parkinsonism & related disorders
Clinical parkinsonism & related disorders
Introduction: The Montreal Cognitive Assessment (MoCA), an instrument widely used for cognitive screening in Parkinson's disease (PD), is validated in Hebrew and English. However, it remains unknown whether the scores are comparable. Methods: The MoC
Autor:
Tanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, Chelsea Caspell-Garcia, Christopher S Coffey, Andrew Siderowf, John Q Trojanowski, Leslie M Shaw, John Seibyl, Andrew Singleton, Arthur W Toga, Doug Galasko, Tatiana Foroud, Duygu Tosun, Kathleen Poston, Daniel Weintraub, Brit Mollenhauer, Caroline M Tanner, Karl Kieburtz, Lana M Chahine, Alyssa Reimer, Samantha J Hutten, Susan Bressman, Kenneth Marek, Vanessa Arnedo, Adrienne Clark, Mark Fraiser, Catherine Kopil, Sohini Chowdhury, Todd Sherer, Nichole Daegele, Cynthia Casaceli, Ray Dorsey, Renee Wilson, Sugi Mahes, Christina Salerno, Karen Crawford, Paola Casalin, Giulia Malferrari, Mali Gani Weisz, Avi Orr-Urtreger, Thomas Montine, Chris Baglieri, Amanda Christini, David Russell, Nabila Dahodwala, Nir Giladi, Stewart Factor, Penelope Hogarth, David Standaert, Robert Hauser, Joseph Jankovic, Marie Saint-Hilaire, Irene Richard, David Shprecher, Hubert Fernandez, Katrina Brockmann, Liana Rosenthal, Paolo Barone, Alberto Espay, Dominic Rowe, Karen Marder, Anthony Santiago, Shu-Ching Hu, Stuart Isaacson, Jean-Christophe Corvol, Javiar Ruiz Martinez, Eduardo Tolosa, Yen Tai, Marios Politis, Debra Smejdir, Linda Rees, Karen Williams, Farah Kausar, Whitney Richardson, Diana Willeke, Shawnees Peacock, Barbara Sommerfeld, Alison Freed, Katrina Wakeman, Courtney Blair, Stephanie Guthrie, Leigh Harrell, Christine Hunter, Cathi-Ann Thomas, Raymond James, Grace Zimmerman, Victoria Brown, Jennifer Mule, Ella Hilt, Kori Ribb, Susan Ainscough, Misty Wethington, Madelaine Ranola, Helen Mejia Santana, Juliana Moreno, Deborah Raymond, Krista Speketer, Lisbeth Carvajal, Stephanie Carvalo, Ioana Croitoru, Alicia Garrido, Laura Marie Payne, Veena Viswanth, Lawrence Severt, Maurizio Facheris, Holly Soares, Mark A. Mintun, Jesse Cedarbaum, Peggy Taylor, Kevin Biglan, Emily Vandenbroucke, Zulfiqar Haider Sheikh, Baris Bingol, Tanya Fischer, Pablo Sardi, Remi Forrat, Alastair Reith, Jan Egebjerg, Gabrielle Ahlberg Hillert, Barbara Saba, Chris Min, Robert Umek, Joe Mather, Susan De Santi, Anke Post, Frank Boess, Kirsten Taylor, Igor Grachev, Andreja Avbersek, Pierandrea Muglia, Kaplana Merchant, Johannes Tauscher
Publikováno v:
The Lancet. Neurology, vol 19, iss 1
Lancet Neurol
Lancet Neurol
BackgroundThe Parkinson's Progression Markers Initiative (PPMI) is an ongoing observational, longitudinal cohort study of participants with Parkinson's disease, healthy controls, and carriers of the most common Parkinson's disease-related genetic mut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9491293206b421c5d364e092f50f0b5a
https://escholarship.org/uc/item/6mc189cw
https://escholarship.org/uc/item/6mc189cw
Autor:
Karen Marder, Anat Mirelman, Laurie J. Ozelius, Avner Thaler, Mali Gana-Weisz, Nir Giladi, Rachel Saunders-Pullman, Helen Mejia-Santana, Susan Bressman, Shiran Shustak, Roy N. Alcalay, Martha Orbe Reilly, Avi Orr-Utreger, Deborah Raymond, Tanya Gurevich, Lorraine N. Clark, Anat Bar-Shira
Publikováno v:
Movement Disorders. 33:966-973
BACKGROUND In 2015, the International Parkinson and Movement Disorder Society Task Force recommended research criteria for the estimation of prodromal PD. OBJECTIVES We aimed to evaluate, for the first time, the criteria in first-degree relatives of
Autor:
Susan B. Bressman, Helen Mejia-Santana, Annie J. Lee, Nir Giladi, Karen Marder, Roy N. Alcalay, Avi Orr-Urtreger, Yuanjia Wang
Publikováno v:
Statistics in Medicine. 36:3533-3546
In genetic epidemiological studies, family history data are collected on relatives of study participants and used to estimate the age-specific risk of disease for individuals who carry a causal mutation. However, a family member's genotype data may n